Thrombospondin 1 - A regulator of adenoma growth and carcinoma progression in the APCMin/+ mouse model

Carcinogenesis

Volumn 24, Issue 2, 2003, Pages 199-207

  Gutierrez, Linda S ^a   Suckow, Mark ^a   Lawler, Jack ^b   Ploplis, Victoria A ^a   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; SCLEROPROTEIN; THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTESTINE CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADENOMA; ANIMALS; CARCINOMA; CELL DIVISION; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; GENES, APC; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MICE; PROLIFERATING CELL NUCLEAR ANTIGEN; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037328393     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/24.2.199     Document Type: Article

References (55)

1. Bornstein,P., Alfi,D., Devarayalu,S., Framson,P. and Li,P. (1990) Characterization of the mouse thrombospondin gene and evaluation of the role of the first intron in human gene expression. J. Biol. Chem., 265, 16691-16698.
2. Bornstein,P., O'Rourke,K., Wikstrom,K., Wolf,F.W., Katz,R., Li,P. and Dixit,V.M. (1991) A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J. Biol. Chem., 266, 12821-12824.
3. Iruela-Arispe,M.L., Liska,D.J., Sage,E.H. and Bornstein,P. (1993) Differential expression of thrombospondin 1, 2 and 3 during murine development. Dev. Dyn., 197, 40-56.
4. Chen,H., Sottile,J., O'Rourke,K.M., Dixit,V.M. and Mosher,D.F. (1994) Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells. J. Biol. Chem., 269, 32226-32232.
5. Pellerin,S., Lafeuillade,B., Chambaz,E.M. and Feige,J.J. (1994) Distinct effects of thrombospondin-1 and CISP/thrombospondin-2 on adrenocortical cell spreading. Mol. Cell. Endocrinol., 106, 181-186.
6. Lafeuillade,B., Pellerin,S., Keramidas,M., Danik,M., Chambaz,E.M. and Feige,J.J. (1996) Opposite regulation of thrombospondin-1 and corticotropin-induced secreted protein/thrombospondin-2 expression by adrenocorticotropic hormone in adrenocortical cells. J. Cell. Physiol., 167, 164-172.
7. Scott-Drew,S. and French-Constant,C. (1997) Expression and function of thrombospondin-1 in myelinating glial cells of the central nervous system. J. Neurosci. Res., 50, 202-214.
8. Aho,S. and Uitto,J. (1998) Two-hybrid analysis reveals multiple direct interactions for thrombospondin 1. Matrix Biol., 17, 401-412.
9. Kyriakides,T.R., Zhu,Y.H., Yang,Z. and Bornstein,P. (1998) The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J. Histochem. Cytochem., 46, 1007-1015.
10. Tooney,P.A., Sakai,J., Sakai,K., Aeschlimann,D. and Mosher,D.F. (1998) Restricted localization of thrombospondin-2 protein during mouse embryogenesis: a comparison to thrombospondin-1. Matrix Biol., 17, 131-143.
11. Kyriakides,T.R., Tam,J.W. and Bornstein,P. (1999) Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J. Invest. Dermatol., 113, 782-787.
12. Vallejo,A.N., Klimiuk,P.A., Weyand,C.M. and Goronzy,J.J. (2000) Central role of thrombospondin-1 in the activation and clonal expansion of cells. J. Immunol., 164, 2947-2954.
13. Fontanini,G., Boldrini,L., Calcinai,A., Chine,S., Lucchi,M., Mussi,A., Angeletti,C.A., Basolo,F. and Bevilacqua,G. (1999) Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors and vascular density. Clin. Cancer Res., 5, 155-161.
14. Dameron,K.M., Volpert,O.V., Tainsky,M.A. and Bouck,N. (1994) Control of angiogenesis in fibroblast by p53 regulation of thrombospondin-1. Science, 265, 1582-1584.
15. Panetti,T.S., Chen,H., Misenheimer,T.M., Getzler,S.B. and Mosher,D.F. (1997) Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J. Lab. Clin. Med., 129, 208-216.
16. Jimenez,B., Volpert,O.V., Crawford,S.E., Febbraio,M., Silverstein,R.L. and Bouck,N. (2000) Signal leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nature Med., 6, 41.
17. Tuszynski,G.P., Smith,M., Rothman,V.L., Capuzzi,M.D., Joseph,R.R., Katz,J., Besa,E.C., Treat,J. and Switalska,H.I. (1992) Thrombospondin 1 levels in patients with malignancy. Thromb. Haemost., 67, 607-611.
18. Clezardin,P., Bruno-Bossio,G., Fontana,A., Serre,C.M., Magnetto,S. and Frappart,L. (1999) Thrombospondins, tumor angiogenesis and breast cancer. Pathol. Biol., 47, 368-374.
19. Tuszynski,G.P., Gasic,T.B., Rothman,V.L., Knudsen,K.A. and Gasic,G.J. (1987) Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res., 147, 4130-4133.
20. Volpert,O.V., Tolsma,S.S., Pellerin,S., Feige,J.J., Chen,H., Mosher,D.F. and Bouck,N. (1995) Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Commun., 217, 326-332.
21. Tolsma,S., Stack,M.S. and Bouck,N. (1997) Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1. Microvascular Res., 54, 13-26.
22. Oshika,Y., Masuda,K., Tokunaga,T. et al. (1998) Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin. Cancer Res., 4, 1785-1788.
23. Kyriakides,T.R., Leach,K.J., Hoffman,A.S., Ratner,B.D. and Bornstein,P. (1999) Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity. Proc. Natl Acad. Sci. USA, 96, 4449-4454.
24. Streit,M., Velasco,P., Brown,L.F., Skobe,M., Richard,L., Riccardi,L., Lawler,J. and Detmar,M. (1999) Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am. J. Pathol., 155, 441-452.
25. Streit,M., Riccardi,L., Velasco,P., Brown,L.F., Hawighorst,T., Bornstein,P. and Detmar,M. (1999) Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl Acad. Sci. USA, 96, 14888-14893.
26. Tokunaga,T., Nakamura,M., Oshika,Y. et al. (1999) Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br. J. Cancer, 79, 354-359.
27. Maeda,K., Nishiguchi,Y., Yashiro,M., Yamada,S., Onoda,N., Sawada,T., Kang,S. and Hirakawa,K. (2000) Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma. Int. J. Mol. Med., 5, 373-378.
28. Tsuchida,T., Kijima,H., Tokunaga,T. et al. (1999) Expression of the thrombospondin 1 receptor CD36 is correlated with decreased stromal vascularisation in colon cancer. Int. J. Oncol., 14, 47-51.
29. Tokunaga,T., Nakamura,M., Oshika,Y. et al. (1998) Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 expression in colon cancer cells. Virchows Arch., 433, 415-418.
30. Bertin,N., Clezardin,P., Kubiak,R. and Frappart,L. (1997) Thrombospondin-1 and -2 messenger RNA expression in normal, benign and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis and fibroblastic desmoplasia. Cancer Res., 57, 396-399.
31. Campbell,S.C., Volpert,O.V., Ivanovich,M. and Bouck,N.P. (1998) Molecular mediators of angiogenesis in bladder cancer. Cancer Res., 58, 1298-1304.
32. Moser,A.R., Pitot,H.C. and Dove,W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
33. Lawler,J., Sunday,M., Thibert,V., Duquette,M., George,E.L., Rayburn,H. and Hynes,R.O. (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest., 101, 982-992.
34. Gavrieli,Y., Sherman,Y. and Ben-Sasson,S. (1992) Identification of programmed cell death in situ specific labeling of nuclear DNA fragmentation. J. Cell. Biol., 119, 493-501.
35. Oshiba,G., Kijima,H., Himeno,S. et al. (1999) Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas. Anticancer Res., 19, 4375-4378.
36. Wong,M., Cheung,N., Yuen,S.T., Leung,S.Y. and Vhung,L.P. (1999) Vascular endothelial growth factor is up regulated in the early pre-malignant stage of colorectal tumor progression. Int. J. Cancer, 81, 845-850.
37. Andre,T., Kotelevets,L., Vaillant,J.C., Coudray,A.M., Weber,L., Prevot,S., Parc,R., Gespach,C. and Chastre,E. (2000) VEGF, VEGF-B, VEGF-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int. J. Cancer, 86, 174-181.
38. Lawler,J., Miao,W.M., Duquette,M., Bouck,N., Bronson,R.T. and Hynes,R.O. (2001) Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. Am. J. Path., 159, 1949-1956.
39. Graeber,T.G., Osmanian,C., Jacks,T., Housman,D.E., Koch,C.J., Lowe,S.W. and Giaccia,A.J. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-92.
40. Murphy-Ullrich,J.E., Schultz-Cherry,S. and Hook,M. (1992) Transforming growth factor-beta complexes with thrombospondin. Mol. Biol. Cell., 3, 181-188.
41. Schultz-Cherry,S. and Murphy-Ullrich,J.E. (1993) Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J. Cell. Biol., 122, 923-932.
42. Roberts,A.B and Sporn,M.B. (1993) Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Fact., 8, 1-9.
43. Hsu,S.C., Volpert,O.V., Steck,P.A., Mikkelsen,T., Polverini,P.J., Rao,S., Chou,P. and Bouck,N.P. (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res., 56, 5684-5691.
44. Zhang,T., Nanney,L.B., Peeler,M.O., Williams,C.S., Lamps,L., Heppner,K.J., DuBois,R.N. and Beauchamp,R.D. (1997) Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression. Cancer Res., 57, 1638-1643.
45. Hao,X., Frayling,I.M., Willcocks,T.C., Han,W., Tomlinson,I.P., Pignatelli,M.N., Pretlow,T.P. and Talbot,I.C. (2002) Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis. Virchows Arch., 440, 362-366.
46. Brabletz,T., Jung,A., Dag,S., Reu,S. and Kirchner,T. (2000) Beta-catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma. Verh. Dtsch. Ges. Pathol., 84, 175-181.
47. Incardona,F., Lewalle,J.M., Morandi,V., Lambert,S., Legrand,Y., Foidart,J.M. and Legrand,C. (1995) Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Cancer Res., 55, 166-173.
48. Goldblum,S.E., Young,B.A., Wang,P. and Murphy-Ullrich,J.E. (1999) Thrombospondin-1 induces tyrosine phosphorylation of adherens junction proteins and regulates an endothelial paracellular pathway. Mol. Biol. Cell., 10, 1537-1551.
49. Arnoletti,J.P., Albo,D., Granick,M.S., Solomon,M.P., Castiglioni,A., Rothman,V.L. and Tuszynski,G.P. (1995) Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer, 76, 998-1005.
50. Gutierrez,L.S., Schulman,A., Brito-Robinson,T., Noria,F., Ploplis,V.A. and Castellino,F.J. (2000) Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res., 60, 5839-5847.
51. Grant,S.W., Kyshtoobayeva,A.S., Kurosaki,T., Jakowatz,J. and Fruehauf,J.P. (1998) Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis and metastatic progression in melanoma. Cancer Detect. Prev., 22, 185-194.
52. Alvarez,A.A., Axelrod,J.R., Whitaker,R.S., Isner,P.D., Bentley,R.C., Dodge,R.K. and Rodriguez,G.C. (2001) Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis and survival in platinum-treated patients. Gynecol. Oncol., 82, 273-278.
53. Kasper,H.U., Ebert,M., Malfertheiner,P., Roessner,A., Kirkpatrick,C.J. and Wolf,H.K. (2001) Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density. Virchows Arch., 438, 116-120.
54. Maeda,K., Nishiguchi,Y., Kang,S.M., Yashiro,M., Onoda,N., Sawada,T., Ishikawa,T. and Hirakawa,K. (2001) Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol. Rep., 8, 763-766.
55. Rodriguez-Manzaneque,J.C., Lane,T.F., Ortega,M.A., Hynes,R.O., Lawler,J. and Iruela-Arispe,M.L. (2001) Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc. Natl Acad. Sci. USA, 98, 12485-23490.